Collection Citation: Kajiru Gad Kilonzo, Stefanie J. Krauth, Jo Halliday, Clive Kelly, Stefan Siebert, Gloria Temu, Christopher Bunn, Nateiya M Yongolo, Sally Wyke, Emma McIntosh, Richard W. Walker, Blandina Mmbaga 2023. Estimating the prevalence, quality of life, economic and societal impact of arthritis in Tanzania: Protocol for a mixed methods study. protocols.io https://dx.doi.org/10.17504/protocols.io.8epv5j8r4l1b/v1
License: This is an open access collection distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this collection and it's working
Created: April 20, 2023
Last Modified: May 19, 2023
Collection Integer ID: 80829
Keywords: musculoskeletal disorders, quality of life, economics, prevalence, Tanzania
Funders Acknowledgement:
The NIHR Global Health Research Group
Grant ID: 17/63/35
Abstract
Introduction
Musculoskeletal (MSK) disorders are one of the major causes of disability globally. A 2010 Global Burden of Disease study reported that MSK diseases account for 20% of all Years Lived with Disability (YLDs) in Low- and Middle-Income countries. This study will use mixed methods to generate new findings on the prevalence, quality of life, economic and societal impact of musculoskeletal disorders (including arthritis) in the Hai district in Tanzania.
Methods and analysis
In this mixed-methods study funded by the UK’s National Institute for Health Research (NIHR) Global Health Research Units and Groups (Award no: 17/63/35) we will conduct quantitative, community-based (urban, peri - urban and rural) and hospital based prospective surveys, supported by rapid ethnographic assessments (REAs), in-depth interviews, focus group discussions (FGDs) and clinical diagnostic screening to estimate the prevalence, economic and societal impact of arthritis. A retrospective medical records baseline review at the Kilimanjaro Christian Medical Centre (KCMC) will also be conducted to assess prevailing documentation and management of arthritis.
Ethics and dissemination
Ethical approval has been obtained through Kilimanjaro Christian Medical University College (KCMUCo) Research Ethics and Review committee (CRERC) in Moshi, National Health Research Ethics Committee (NatHREC) of the National Institute for Medical research (NIMR) in Tanzania and the Medical Veterinary and Life Sciences (MVLS) Ethics committee at the University of Glasgow, UK (MVLS ethics project number:20018010). We will disseminate the findings in clinical, epidemiological, and economic peer reviewed journals. Other dissemination modalities include professional conferences, short reports, community leaflets, policy briefs and dissemination events to communities and various stakeholders including the Ministry of health in Tanzania.
In relation to their huge disability burden, the diagnosis, treatment and management of musculoskeletal (MSK) disorders have received inadequate attention worldwide.(1,2) This is particularly true for the global south, especially East Africa where infectious diseases such as malaria, tuberculosis and HIV have traditionally consumed much of the health care resources.(3) With strategies to control many communicable diseases now being identified and implemented, attention is turning to the ever-growing health and economic challenges associated with non-communicable diseases (NCDs). Among NCDs, MSK disorders are not typically prioritised for a number of reasons including the notion that they carry a low mortality compared to the diseases mentioned in the Sustainable Development Goals.(1,2) However, MSK disorders are the largest contributor to Years Lived with Disability (YLD) worldwide, amounting to 149 million YLD.(4) Indirect costs such as lost work productivity caused by MSK disorders and arthritis are known to be greater than their direct health care costs.(5–9). This is particularly pertinent to populations already experiencing significant poverty such as those in low resource settings such as Tanzania. The prevalence of MSK and arthritis is hypothesised to be high in Tanzania and this is likely to have even greater impacts on poverty because of inability to work (indirect cost impacts) and wider household/agricultural productivity impacts as well as inability to fulfil community roles. Such high indirect costs and compounding impacts upon quality of life and depression are well documented in developing countries but little evidence exists for Tanzania. The health and economic burdens of MSK disorders are almost entirely under-reported in sub-Saharan Africa (SSA), including East Africa.
The existing evidence on the prevalence of MSK and arthritis is sparse with highly inconsistent estimates for SSA. A review revealed the prevalence of joint pain between 20% and 33% among people in lower- and middle-income countries.(10,11) MSK studies in SSA have typically focussed on Rheumatoid Arthritis (RA) which carries a high morbidity and considerable mortality in SSA. (12) A systematic review of the prevalence of arthritis in Africa (13), identified the paucity of recent clinical data from SSA, outside South Africa. Over a period of almost forty years, twenty-seven studies assessed the prevalence of arthritis in Africa with only one of these carried out in SSA and this was focussed on HIV related disease. (13,14) In Tanzania, the morbidity associated with arthritis was found to be significant in a hospital-based study with over 60% of patients requiring assistance with mobility and very few managing to access specialist care at a distant centre. (15) Populations in low resource settings clearly carry the burden of MSK disorders but have fewer resources , including adequate service provision, to diagnose and treat such conditions. A study that explores both community and hospital prevalence and case mix, quantifies the economic and quality of life impacts and illuminates personal experiences and existing management strategies has the potential to inform future policy and health care practice for the largely undiagnosed population who suffer silently from MSK disorders.
Early and intensive treatment of MSK disorders including inflammatory arthritis has been demonstrated to improve functional outcomes among patients (16). Reliable local data on the burden of MSK disorders therefore has the potential to strengthen advocacy in resource allocation for early intervention leading to decreased disability and higher quality of life. There has been increasing recognition of the need for action in SSA with input from the International League Against Rheumatism (ILAR) (17) and the African League against Rheumatism (AFLAR)(3). However, in Tanzania there are presently no data on the prevalence of arthritis, nor on how people experience and manage the disease or the impact it has on income, productivity, health care expenditure and quality of life. The need to assess community prevalence in tandem with a hospital-based survey is paramount to understanding the prevailing burden of MSK disorders in general and particularly arthritis. Such insight will inform requirements for local capacity building in MSK.
Study settings
This study is being conducted in the Kilimanjaro region of Tanzania, commencing April 2018. The regional population is more than 1,600,000 individuals of whom about one third live in urban areas(4). The main ethnic group is the Chagga who are distributed in seven districts. These studies are being conducted in two of these districts, Moshi urban and Hai district. The Hai district was selected because it is an established site for demographic surveillance in Tanzania(18). The Hai district which is in the Kilimanjaro highlands (approximately 1900 metres above sea level) of Kilimanjaro is mainly made up of subsistence farms but also cash crops such as coffee. In contrast, Moshi urban is in the Kilimanjaro lowlands (approximately
900 metres above sea level) with temperatures between 37 degrees centigrades and 24 degrees centigrades.(19) Moshi urban was selected by convenience of location of an urban population. The lowest organisational unit at a Tanzanian street or village level is the Ten cell leader also known as a Balozi.(20) Several 10-cell leaders comprise a village which is the lowest administrative structure in the rural setting. Several villages then make up a ward followed by a district and then a region. In the urban setting, streets are in place of villages.
Objectives and Research Questions
This research study has the following objectives:
To estimate the prevalence of the main forms of MSK in hospital and community settings in the Hai district in Tanzania.
To estimate the frequency of comorbid NCDs, especially with reference to those associated with arthritis and its treatment, in the community and a hospital setting in the Hai district in Tanzania.
To assess how arthritis is understood by community members, health care professionals and patients in the Hai district in Tanzania.
To describe the experiences of living with joint pain and arthritis in the Hai district in Tanzania.
To describe the management of arthritis in a Tanzanian clinical setting.
To adopt and pilot instruments to measure arthritis quality of life (QOL), health seeking behaviour & resource utilisation in community and hospital settings in the Hai district in Tanzania.
Based on these objectives, this study has four key research questions:
What is the lived experience of joint pain and arthritis in Tanzania?
What instruments are best suited to measuring & valuing quality of life and resource use
What is the extent and nature of joint pain and arthritis in clinical settings in Tanzania?
What is the prevalence, health, economic and societal burden of the main forms of arthritis in Tanzania?
In Tanzania can they be administered within a household survey?
Consenting
In all methods described, apart from the retrospective survey, consent will be sought for the collection of data collected on individuals’ joint pain, co-morbidities related health, economic, and quality of life. Children aged 5-17 attending as inpatients will be consented via their parents/guardians, who will be provided with a PIS and sign informed consent for their children to participate. In addition to parental consent, children aged 12-17 will be asked to assent to their participation. For individuals who do not wish to participate, researchers will note their estimated age and gender to assess whether the data is subject to a participation bias. The study will not collect any other data from non-consenting individuals, and participants will not be approached again.
Dissemination and Implications of expected results
We will disseminate the findings in manuscripts in clinical, epidemiological, and economic peer reviewed journals. Other dissemination modalities include professional conferences, short reports, community leaflets, policy briefs and dissemination events to communities and various stakeholders including the Ministry of health in Tanzania. The results from this study will be used to guide clinical health practice, intervention design, service provision, socio cultural practices and health promotion and awareness activities both at KCMC institutional level, Kilimanjaro region and at national level. This study will highlight the prevalence of rheumatological conditions and the scope of their economic and societal impact. This research will guide Tanzania and wider SSA strategy and policy making process towards increased focus and attention to neglected rheumatological diseases. This study will act as a baseline study to be used as reference by future studies, interventions, and scientific ventures on the topic nationally and internationally.
Author Contributions
A
B
Emma McIntosh (PhD)-University of Glasgow
Original Idea
Blandina Mmbaga (MMED) - Kilimanjaro Christian Medical Centre (KCMC)
Sarah Cleaveland (PhD) - University of Glasgow
Iain McInnes (PhD) - University of Glasgow
Kajiru Gad Kilonzo (MMED) – KCMC
Initial draft and revisions
Shadrach Dare (PhD) - University of Glasgow
Stefanie J. Krauth
Richard W. Walker
Nateiya M Yongolo - KCRI
Emma McIntosh - University of Glasgow
Blandina Mmbaga – KCRI/KCMC
Emma Laurie (PhD) - University of Glasgow
Draft contributions and revisions
Iain Mclnnes (MD) - University of Glasgow
Sally Wyke (PhD) - University of Glasgow
Dan Haydon (PhD) - University of Glasgow
Design
Stefan Siebert (MD, PhD) - University of Glasgow
Methodology
Jo Halliday (PhD) - University of Glasgow
Christopher Bunn (PhD) - University of Glasgow
Eleanor Grieve (PhD) - University of Glasgow
Manuela Deidda (PhD) - University of Glasgow
Emma McIntosh (PhD) - University of Glasgow
Richard W. Walker (MD) - Northumbria Healthcare NHS Foundation Trust
Clive Kelly (MD) - Newcastle University
Stefanie J. Krauth (PhD) - University of Glasgow
Shadrach Dare - Glasgow Caledonian University
Gloria Temu (MMED) - KCMC
Ireen Kiwelu (PhD) - Kilimanjaro Clinical Research Institute (KCRI)
Elizabeth Msoka (MSc) - KCRI
Kiula Peter Kiula (MSc) – KCRI/IRDP
Manasseh Mwanswila (BSc) - KCRI
Rose Monica Ongara (MSc) - KCRI
Sanjura M. Biswaro (MD) – KCRI
Anthon Mwingwa MD - KCRI
Acknowledgement
This study was funded by the NIHR Global Health Research Group on Musculoskeletal disorders and Arthritis (17/63/35). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.
Analysis of qualitative data, Statistical Analysis and Health Economic Analysis
Version 1
Yujin Du
Protocol references
References
1. United Nations. Transforming our world: the 2030 Agenda for Sustainable Development. United Nations General Assembly; 2015 Oct. Report No.: 70/1.
2. Briggs AM, Woolf AD, Dreinhöfer K, Homb N, Hoy DG, Kopansky-Giles D, et al. Reducing the global burden of musculoskeletal conditions. Bull World Health Organ. 2018 May 1;96(5):366–8.
3. Mody GM. Rheumatology in Africa-challenges and opportunities. Arthritis Res Ther [Internet]. 2017 Mar;19(1). Available from: https://pubmed.ncbi.nlm.nih.gov/28270202/
4. Basic Demongraphic and Socio-Economic Profile. Kilimanjaro Region. 2012 Population and Housing Census. Dar es salaam; 2016 p. 1–133.
5. Raciborski F, Kłak A, Kwiatkowska B. Indirect costs of rheumatoid arthritis. Reumatologia. 2015;53(5):268–268.
6. Hamuryudan V, Direskeneli H, Ertenli I. The European Scleroderma Observational Study (ESOS) View project Behcet disease View project. 2016; Available from: https://www.researchgate.net/publication/309232789
7. Kvamme MK, Lie E, Kvien TK, Kristiansen IS. Two-year direct and indirect costs for patients with inflammatory rheumatic joint diseases: data from real-life follow-up of patients in the NOR-DMARD registry. Rheumatology. 2012 Sep;51(9):1618–27.
8. Batko B, Rolska-Wójcik P, Władysiuk M. Indirect Costs of Rheumatoid Arthritis Depending on Type of Treatment—A Systematic Literature Review. Int J Environ Res Public Health 2019 Vol 16 Page 2966. 2019 Aug;16(16):2966–2966.
9. Rheumatology EM, 1996 undefined. The cost of rheumatoid arthritis. academic.oup.com [Internet]. Available from: https://academic.oup.com/rheumatology/article-abstract/35/8/781/1782940
10. Courage UU, Stephen DP, Lucius IC, Ani C, Oche AO, Emmanuel AI, et al. Prevalence of musculoskeletal diseases in a semi-urban Nigerian community: results of a cross-sectional survey using COPCORD methodology.
12. Dowman B, Campbell RM, Zgaga L, Adeloye D, Chan KY. Estimating the burden of rheumatoid arthritis in Africa: A systematic analysis. J Glob Health. 2012;2(2).
13. Usenbo A, Kramer V, Young T, Musekiwa A. Prevalence of Arthritis in Africa: A Systematic Review and Meta-Analysis. Nurmohamed M, editor. PLOS ONE. 2015 Aug;10(8):e0133858–e0133858.
14. Kaddu-Mukasa M, Ssekasanvu E, Ddumba E, Thomas D, Katabira ET. Rheumatic manifestations among HIV positive adults attending the Infectious Disease Clinic at Mulago hospital. Afr Health Sci. 2011;11(1):24–9.
15. Mwanjela R. Non- Taumatic arthritidea: causes and outcome in patients admitted to muhimbili medical cetre,Dar es Salaam,tanzania in !992. Thesis. Muhimbili University of Health and Allied Sciences; 1993. p. 75.
16. Gullick NJ, Ibrahim F, Scott IC, Vincent A, Cope AP, Garrood T, et al. Real world long-term impact of intensive treatment on disease activity, disability and health-related quality of life in rheumatoid arthritis. BMC Rheumatol. 2019 Feb;3(1):1–10.
17. Genga EK, Moots RJ, Oyoo OG, Otieno FO. Building a rheumatology team for East AfricaA call for action! Rheumatology. 2017 Sep;56(9):1441–2.
18. Tanzania Demographic and Health Survey and Malaria Indicator Survey 2015-2016 [Internet]. Tanzania: Ministry of Health, Community Development, Gender, Elderly and Children - MoHCDGEC/Tanzania Mainland, Ministry of Health - MoH/Zanzibar, National Bureau of Statistics - NBS/Tanzania, Office of Chief Government Statistician - OCGS/Zanzibar, and ICF.; 2016 Dec [cited 2022 Apr 16]. Available from: https://dhsprogram.com/publications/publication-FR321-DHS-Final-Reports.cfm
19. Kulkarni MA, Desrochers RE, Kajeguka DC, Kaaya RD, Tomayer A, Kweka EJ, et al. 10 Years of Environmental Change on the Slopes of Mount Kilimanjaro and Its Associated Shift in Malaria Vector Distributions. Front Public Health [Internet]. 2016 [cited 2022 Mar 26];4. Available from: https://www.frontiersin.org/article/10.3389/fpubh.2016.00281
20. Shadrack JT. Privatised policing duties in a constitutional state: the case of postcolonial Tanzania in socio-legal context [Internet] [PhD]. University of Warwick; 2020 [cited 2022 Mar 28]. Available from: http://webcat.warwick.ac.uk/record=b3710625
21. Harris KJ, Jerome NW, Fawcett SB. Rapid Assessment Procedures: A Review and Critique. Hum Organ. 1997;56(3):375–8.
22. Corbin J, Strauss A. Managing chronic illness at home: Three lines of work. Qual Sociol. 1985 Sep 1;8(3):224–47.
23. Pink S, Morgan J. Short-Term Ethnography: Intense Routes to Knowing. Symb Interact. 2013;36(3):351–61.
24. Hahn RA, Inborn M, editors. Anthropology and Public Health: Bridging Differences in Culture and Society [Internet]. 2nd ed. New York: Oxford University Press; 2009 [cited 2022 Mar 27]. 752 p. Available from: https://oxford.universitypressscholarship.com/10.1093/acprof:oso/9780195374643.001.0001/acprof-9780195374643
25. Division UNS. Designing household survey samples : U N. 2008;ST/ESA/STA(F No. 98):264–264.
26. Doherty M, Dacre J, Dieppe P, Snaith M. The ‘GALS’ locomotor screen. Ann Rheum Dis. 1992;51(10):1165–9.
27. Foster HE, Jandial S. PGALS - paediatric Gait Arms Legs and Spine: A simple examination of the musculoskeletal system. Pediatr Rheumatol. 2013 Nov;11(1):1–7.
28. Smith E, Molyneux E, Heikens GT, Foster H. Acceptability and practicality of pGALS in screening for rheumatic disease in Malawian children. Clin Rheumatol. 2012 Apr;31(4):647–53.
29. Measuring health and disability : manual for WHO Disability Assessment Schedule (WHODAS 2.0) [Internet]. [cited 2023 Apr 16]. Available from: https://www.who.int/publications-detail-redirect/measuring-health-and-disability-manual-for-who-disability-assessment-schedule-(-whodas-2.0)
30. EuroQol Group. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy Amst Neth. 1990 Dec;16(3):199–208.
31. Stevens K. Developing a descriptive system for a new preference-based measure of health-related quality of life for children. Qual Life Res. 2009 Oct;18(8):1105–13.
32. ODK - Collect data anywhere [Internet]. [cited 2022 Mar 28]. Available from: https://getodk.org
33. Hood C, Johnson J, Kelly C. What is the prevalence of rheumatic disorders in general medical inpatients? Postgrad Med J. 2001 Dec;77(914):774–7.
34. Green J, Thorogood N. Qualitative Methods for Health Research. SAGE; 2018. 441 p.
